Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity. (Q51050853)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387260%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387260%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

0 references

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387260%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

Fernando Lara-Medina

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387260%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Víctor Pérez-Sánchez

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387260%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

David Saavedra-Pérez

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387260%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Monika Blake-Cerda

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387260%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Claudia Arce

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387260%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Daniel Motola-Kuba

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387260%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Cynthia Villarreal-Garza

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387260%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Ana Maria González-Angulo

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387260%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Enrique Bargalló

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387260%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Jose Luis Aguilar

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387260%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Alejandro Mohar

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387260%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

language of work or name

0 references

publication date

8 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387260%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387260%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

117

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387260%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387260%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

3658-3669

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387260%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Current status of estrogen and progesterone receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Refinement of breast cancer classification by molecular characterization of histological special types

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Triple-negative breast cancer: clinical features and patterns of recurrence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Triple-negative breast cancer: risk factors to potential targets

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Triple-negative breast cancers are increased in black women regardless of age or body mass index

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Survival among women with triple receptor-negative breast cancer and brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Weight gain prior to diagnosis and survival from breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

The epidemiology of triple-negative breast cancer, including race

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Epidemiology of obesity in the Western Hemisphere

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Obesity prevalence and trends in Latin-American countries

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Tumor characteristics in African American and white women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Distribution of molecular breast cancer subtypes in middle eastern-saudi arabian women: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Triple negative breast carcinoma is a prognostic factor in Taiwanese women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Progressive loss of estrogen receptor alpha cofactor recruitment in endocrine resistance.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Obesity as a risk factor for development and poor prognosis of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Obesity and outcomes in premenopausal and postmenopausal breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Adiposity, adult weight change, and postmenopausal breast cancer risk

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Variation in breast cancer hormone receptor andHER2levels by etiologic factors: A population-based analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

First breast cancer mammography screening program in Mexico: initial results 2005-2006.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Impact of triple negative phenotype on breast cancer prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Clinicopathologic and prognostic characteristics of triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Epidemiology of basal-like breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Risk factors for triple-negative breast cancer in women under the age of 45 years

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

21 January 2018

Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

7 January 2021

based on heuristic

inferred from DOI database lookup

Ethnicity and breast cancer: factors influencing differences in incidence and outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in breast cancer by race and ethnicity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

7 January 2021

based on heuristic

inferred from DOI database lookup

HER-2/neu genotype of breast cancer may change in bone metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

7 January 2021

based on heuristic

inferred from DOI database lookup

Histological grade in invasive ductal carcinoma of breast correlates with the proliferative activity evaluated by BrdU: an immunohistochemical study including correlations with p53, c-erbB-2 and estrogen receptor status

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25961

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51050853&oldid=1424908628"